[For more current case annotated texts by this author, see Bernstein & Lookofsky, Understanding the CISG in Europe, 2d ed. (2003) and Lookofsky, Understanding the CISG in the USA, 2d ed. (2004).]
excerpt from
Joseph Lookofsky
220. By providing a seller who delivers before the contract date with a certain right to 'cure' non-conformities (defects) in the goods so delivered, Article 37 gives the seller a chance to limit the damage caused by the breach and also to limit the scope of remedial relief otherwise available to the injured buyer.[1] Article 48(1) supplements this early-delivery rule with a more limited right for the seller to cure defects after the delivery date:
221. Mistakes will happen, inter alia, in international trade: (some) of the goods delivered may not conform to the contract, a third party's interest may appear to conflict, the documents may be defective in some respect, etc. In most such situations, an effective remedy by the seller of her failure to perform in full - even where such 'cure' takes place after the contractual delivery date - may be preferable to an avoidance of the contract: this will surely be the case for the seller, and it [page 121] may also even be true for the buyer. To exercise her right under Article 48(1), however, the seller must produce a cure which is quick, convenient and certain as seen from buyer's point of view.
2. Relation Between Cure and Avoidance Under Article 49
222. Article 48(1) starts with a 'subject to Article 49' reference which is not completely clear on its face, and neither the legislative history nor (as yet) the CISG case law has clarified the relationship between these important provisions.
On the other hand, there does seem to be an emerging consensus that, in most cases, the seller should be allowed to remedy even serious defects in accordance with Article 48(1), i.e., even in cases where a given non-conforming delivery might otherwise seem to fall within the scope of the fundamental breach rule in Article 49. The reason for this is the existence of a 'dynamic' relationship among Articles 25, 48(1) and 49, the idea being that when a given non-conformity can be cured without great inconvenience to the buyer, then that non-conformity should not be regarded as a fundamental breach.
So, except in cases where a given breach remains 'incurable' (by reasonable means), most commentators agree that a seller's good-faith offer to cure ought not be defeated by the buyer's right to avoid for a fundamental breach.[1]
3. Proposals and Notice by Seller Regarding Cure
223. The remainder of Article 48, paragraphs (2)-(4), contains a series of logical rules regarding proposals and notice by the seller regarding cure.[1]
Pace Law School
Institute of International Commercial Law - Last updated April 5, 2005